相关产品推荐更多 >

Purified recombinant protein of Mouse myoglobin (Mb), with C-terminal MYC/DDK tag, expressed in HEK293T cells, 20ug
¥2900
Purified recombinant protein of Mouse fibrinogen gamma chain (Fgg), with C-terminal MYC/DDK tag, expressed in HEK293T cells, 20ug
¥2900
Recombinant protein of human nucleoporin 43kDa (NUP43), transcript variant 1
¥2900
Purified recombinant protein of Homo sapiens heterogeneous nuclear ribonucleoprotein C (C1/C2) (HNRNPC), transcript variant 3
¥2900
Purified recombinant protein of Homo sapiens family with sequence similarity 90, member A18 (FAM90A18)
¥2900
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
AJE 润色服务限时 8 折起,权威机构信任 15+ 年Cytoscape 教程来了!快速实现顶刊同款通路网络图五大应用案例:Mustang Q 膜层析应用全解析1 个小工具,一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Store at -80°C.
- 保质期:
Stable for 12 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles.
- 英文名:
Purified recombinant protein of Human glial cell derived neurotrophic factor (GDNF), transcript variant 3, full length, with N-terminal HIS tag, expressed in E.Coli, 50ug
- 供应商:
OriGene
- 规格:
50 ug
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Culture of Purified Glial Cell Populations from Optic Nerve
Glial cells play a key role in nervous system function, providing neurotrophic factor support to neurons as well as taking part in two-way neuron-glia signaling (e.g., neurotransmitter release). White matter-derived glia are important
Expression and Purification Methods for the Production of Recombinant Human Complement Component C2
Human complement component C2 is a critical factor of the classical complement pathway. Here we provide a method for the production of recombinant human C2 (rhC2) protein for research purposes. The human complement component C2 (hC
Ex Vivo Stromal Cell Electroporation of Factor IX cDNA for Treatment of Hemophilia B
of bleeding episodes and reduce long term complications (3). Treatment of hemophilia B primarily relies on intravenous injections of FIX protein purified from pooled human plasma, or very recently, on newly developed recombinant FIX. Treatment is applied
技术资料暂无技术资料 索取技术资料






